These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8442399)

  • 1. Serum and CSF levels of soluble interleukin-2 receptors in MS and other neurological diseases: a reappraisal.
    Chalon MP; Sindic CJ; Laterre EC
    Acta Neurol Scand; 1993 Feb; 87(2):77-82. PubMed ID: 8442399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors.
    Hartung HP; Hughes RA; Taylor WA; Heininger K; Reiners K; Toyka KV
    Neurology; 1990 Feb; 40(2):215-8. PubMed ID: 2300238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis.
    Sharief MK; Thompson EJ
    J Neurol Neurosurg Psychiatry; 1993 Feb; 56(2):169-74. PubMed ID: 8437006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis.
    Vedeler CA; Matre R; Sadallah S; Schifferli J
    J Neuroimmunol; 1996 Jun; 67(1):17-20. PubMed ID: 8707926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum soluble interleukin-2 receptor levels in chronic progressive, stable and steroid-treated multiple sclerosis.
    Bansil S; Troiano R; Cook SD; Rohowsky-Kochan C
    Acta Neurol Scand; 1991 Oct; 84(4):282-5. PubMed ID: 1772000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome.
    Patzold T; Sindern E; Ossege-Pohle L; Malin JP
    J Neurol; 1998 Dec; 245(12):803-8. PubMed ID: 9840353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system.
    Trojano M; Avolio C; Ruggieri M; De Robertis F; Giuliani F; Paolicelli D; Livrea P
    Mult Scler; 1998 Feb; 4(1):39-44. PubMed ID: 9532592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis.
    Carrieri PB; Soscia E; Iacovitti B; Pellicano M; D'Antonio A; Provitera V; Perrella O
    Eur Cytokine Netw; 1992; 3(5):495-8. PubMed ID: 1477299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system.
    Kastenbauer S; Koedel U; Wick M; Kieseier BC; Hartung HP; Pfister HW
    J Neuroimmunol; 2003 Apr; 137(1-2):210-7. PubMed ID: 12667665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo relationship of interleukin-2 and soluble IL-2 receptor to blood-brain barrier impairment in patients with active multiple sclerosis.
    Sharief MK; Hentges R; Ciardi M; Thompson EJ
    J Neurol; 1993 Jan; 240(1):46-50. PubMed ID: 8423463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroimmunological findings in Guillain Barré syndrome, multiple sclerosis, and idiopathic polyneuropathies.
    Dorta-Contreras A; Silva-Somoza R
    Mol Chem Neuropathol; 1996; 28(1-3):279-84. PubMed ID: 8871970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis.
    Petereit HF; Reske D; Tumani H; Jarius S; Markus Leweke F; Woitalla D; Pfister HW; Rubbert A
    J Neurol; 2010 Nov; 257(11):1855-63. PubMed ID: 20556411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases.
    Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D
    Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlation with serum-soluble interleukin-2 receptor levels in Guillain-Barré syndrome.
    Bansil S; Mithen FA; Cook SD; Sheffet A; Rohowsky-Kochan C
    Neurology; 1991 Aug; 41(8):1302-5. PubMed ID: 1866024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against oligodendrocytes in serum and CSF in multiple sclerosis and other neurological diseases: 125I-protein A studies.
    Steck AJ; Link H
    Acta Neurol Scand; 1984 Aug; 70(2):81-9. PubMed ID: 6485748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis.
    Tsukada N; Miyagi K; Matsuda M; Yanagisawa N; Yone K
    J Neurol Sci; 1991 Aug; 104(2):230-4. PubMed ID: 1940977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell phenotypic profiles in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients.
    Scolozzi R; Boccafogli A; Tola MR; Vicentini L; Camerani A; Degani D; Granieri E; Caniatti L; Paolino E
    J Neurol Sci; 1992 Mar; 108(1):93-8. PubMed ID: 1352538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticardiolipin antibodies in patients with rabies vaccination induced neurological complications and other neurological diseases.
    Chaleomchan W; Hemachudha T; Sakulramrung R; Deesomchok U
    J Neurol Sci; 1990 May; 96(2-3):143-51. PubMed ID: 2376746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal-fluid ciliary neurotrophic factor in neurological patients.
    Massaro AR; Soranzo C; Carnevale A
    Eur Neurol; 1997; 37(4):243-6. PubMed ID: 9208266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.